Zynex Cost of Goods Sold 2010-2024 | ZYXI
Zynex cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Zynex Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $38 |
| 2022 | $32 |
| 2021 | $27 |
| 2020 | $17 |
| 2019 | $9 |
| 2018 | $6 |
| 2017 | $5 |
| 2016 | $4 |
| 2015 | $5 |
| 2014 | $8 |
| 2013 | $8 |
| 2012 | $9 |
| 2011 | $7 |
| 2010 | $5 |
| 2009 | $4 |
| Zynex Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-03-31 | $9 |
| 2023-12-31 | $10 |
| 2023-09-30 | $10 |
| 2023-06-30 | $9 |
| 2023-03-31 | $9 |
| 2022-12-31 | $9 |
| 2022-09-30 | $8 |
| 2022-06-30 | $7 |
| 2022-03-31 | $7 |
| 2021-12-31 | $7 |
| 2021-09-30 | $7 |
| 2021-06-30 | $7 |
| 2021-03-31 | $6 |
| 2020-12-31 | $6 |
| 2020-09-30 | $4 |
| 2020-06-30 | $4 |
| 2020-03-31 | $3 |
| 2019-12-31 | $3 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $2 |
| 2018-12-31 | $1 |
| 2018-09-30 | $2 |
| 2018-06-30 | $1 |
| 2018-03-31 | $3 |
| 2017-12-31 | $2 |
| 2017-09-30 | $1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $-2 |
| 2016-09-30 | $1 |
| 2016-06-30 | $1 |
| 2016-03-31 | $4 |
| 2015-12-31 | $2 |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $4 |
| 2014-03-31 | $1 |
| 2013-12-31 | $3 |
| 2013-09-30 | $2 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $3 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $2 |
| 2011-12-31 | $2 |
| 2011-09-30 | $2 |
| 2011-06-30 | $2 |
| 2011-03-31 | $1 |
| 2010-12-31 | $2 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $2 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.336B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.113B | 23.45 |
| Stryker (SYK) | United States | $125.908B | 30.16 |
| Medtronic (MDT) | Ireland | $113.091B | 16.01 |
| Boston Scientific (BSX) | United States | $111.015B | 35.36 |
| EssilorLuxottica (ESLOY) | France | $103.060B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.904B | 28.40 |
| ResMed (RMD) | United States | $32.067B | 30.11 |
| Terumo (TRUMY) | Japan | $25.670B | 36.25 |
| Koninklijke Philips (PHG) | Netherlands | $25.361B | 19.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.482B | 15.64 |
| Baxter (BAX) | United States | $17.555B | 12.48 |
| Insulet (PODD) | United States | $12.803B | 56.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $11.282B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.257B | 27.00 |
| BellRing Brands (BRBR) | United States | $7.602B | 35.76 |
| Lantheus Holdings (LNTH) | United States | $5.594B | 13.94 |
| Haemonetics (HAE) | United States | $4.738B | 23.42 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.050B | 12.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.247B | 15.45 |
| Envista Holdings (NVST) | United States | $3.154B | 13.01 |
| Neogen (NEOG) | United States | $2.896B | 27.85 |
| QuidelOrtho (QDEL) | United States | $2.769B | 15.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.753B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.659B | 52.67 |
| TG Therapeutics (TGTX) | United States | $2.565B | 72.17 |
| ICU Medical (ICUI) | United States | $2.503B | 22.09 |
| Agios Pharmaceuticals (AGIO) | United States | $1.923B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.768B | 51.81 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Warby Parker (WRBY) | United States | $1.675B | 0.00 |
| InMode (INMD) | Israel | $1.575B | 8.37 |
| Owens & Minor (OMI) | United States | $1.352B | 11.78 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.66 |
| National Vision Holdings (EYE) | United States | $1.241B | 39.50 |
| AtriCure (ATRC) | United States | $1.068B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.998B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.851B | 0.00 |
| Evolus (EOLS) | United States | $0.824B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.744B | 15.84 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Quanterix (QTRX) | United States | $0.642B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.610B | 14.35 |
| PetIQ (PETQ) | United States | $0.596B | 19.47 |
| Valneva SE (VALN) | France | $0.571B | 0.00 |
| Surmodics (SRDX) | United States | $0.498B | 31.15 |
| TerrAscend (TSNDF) | Canada | $0.487B | 0.00 |
| ZimVie (ZIMV) | United States | $0.472B | 40.19 |
| Jin Medical (ZJYL) | China | $0.445B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.389B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.362B | 11.67 |
| Biote (BTMD) | United States | $0.346B | 7.96 |
| Cerus (CERS) | United States | $0.342B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 27.04 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| MacroGenics (MGNX) | United States | $0.267B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.267B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 15.27 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Veru (VERU) | United States | $0.203B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
| InterCure (INCR) | Israel | $0.150B | 25.39 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.17 |
| Cellectar Biosciences (CLRB) | United States | $0.117B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 7.83 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| MariMed (MRMD) | United States | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.70 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |